Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Douglas Faries

Showing results (1-10 of 41) with videos related to

Pageof 5
Sort By:
Journal of Biopharmaceutical Statistics|September 22, 2007
Analysis of treatment effectiveness in longitudinal observational dataDouglas Faries, Haya Ascher-Svanum, Mark Belger
Pharmaceutical Statistics|October 6, 2015
Adaptive truncated weighting for improving marginal structural model estimation of treatment effects informally censored by subsequent therapyXiaofei Bai, Jingyi Liu, Li Li, et al.
Journal of Pain Research|July 14, 2012
Predictors of duloxetine adherence and persistence in patients with fibromyalgiaZhanglin Cui, Yang Zhao, Diego Novick, et al.
Journal of Biopharmaceutical Statistics|January 23, 2023
Reweighting estimators to extend the external validity of clinical trials: methodological considerationsEloise Kaizar, Chen-Yen Lin, Douglas Faries, et al.
Human Psychopharmacology|October 31, 2002
Moxonidine versus placebo as an aid in smoking cessationLouise R Levine, Philip Tonneson, Poul Wennike, et al.
Drug Safety|October 20, 2005
Detecting treatment emergent adverse events in clinical trials : a comparison of spontaneously reported and solicited collection methodsJoachim F Wernicke, Douglas Faries, Denái Milton, et al.
Journal of Cardiovascular Electrophysiology|January 28, 2005
QT correction methods in children and adolescentsJoachim F Wernicke, Douglas Faries, Rebecca Breitung, et al.
Pharmaceutical Statistics|March 6, 2021
A comparison of reweighting estimators of average treatment effects in real world populationsChen-Yen Lin, Eloise Kaizar, Douglas Faries, et al.
Annals of General Hospital Psychiatry|June 4, 2004
A comparison of olanzapine and risperidone on the risk of psychiatric hospitalization in the naturalistic treatment of patients with schizophreniaHaya Ascher-Svanum, Baojin Zhu, Douglas Faries, et al.
Trials|November 5, 2015
A literature review on the representativeness of randomized controlled trial samples and implications for the external validity of trial resultsTessa Kennedy-Martin, Sarah Curtis, Douglas Faries, et al.
Pageof 5

Showing results (1-10 of 41) with videos related to

Sort By:
Pageof 5
Journal of Biopharmaceutical Statistics|September 22, 2007
Analysis of treatment effectiveness in longitudinal observational dataDouglas Faries, Haya Ascher-Svanum, Mark Belger
Pharmaceutical Statistics|October 6, 2015
Adaptive truncated weighting for improving marginal structural model estimation of treatment effects informally censored by subsequent therapyXiaofei Bai, Jingyi Liu, Li Li, et al.
Journal of Pain Research|July 14, 2012
Predictors of duloxetine adherence and persistence in patients with fibromyalgiaZhanglin Cui, Yang Zhao, Diego Novick, et al.
Journal of Biopharmaceutical Statistics|January 23, 2023
Reweighting estimators to extend the external validity of clinical trials: methodological considerationsEloise Kaizar, Chen-Yen Lin, Douglas Faries, et al.
Human Psychopharmacology|October 31, 2002
Moxonidine versus placebo as an aid in smoking cessationLouise R Levine, Philip Tonneson, Poul Wennike, et al.
Drug Safety|October 20, 2005
Detecting treatment emergent adverse events in clinical trials : a comparison of spontaneously reported and solicited collection methodsJoachim F Wernicke, Douglas Faries, Denái Milton, et al.
Journal of Cardiovascular Electrophysiology|January 28, 2005
QT correction methods in children and adolescentsJoachim F Wernicke, Douglas Faries, Rebecca Breitung, et al.
Pharmaceutical Statistics|March 6, 2021
A comparison of reweighting estimators of average treatment effects in real world populationsChen-Yen Lin, Eloise Kaizar, Douglas Faries, et al.
Annals of General Hospital Psychiatry|June 4, 2004
A comparison of olanzapine and risperidone on the risk of psychiatric hospitalization in the naturalistic treatment of patients with schizophreniaHaya Ascher-Svanum, Baojin Zhu, Douglas Faries, et al.
Trials|November 5, 2015
A literature review on the representativeness of randomized controlled trial samples and implications for the external validity of trial resultsTessa Kennedy-Martin, Sarah Curtis, Douglas Faries, et al.
Pageof 5